| EP3154553 - ENTERIC ELASTOMERS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 11.06.2021 Database last updated on 09.04.2026 | |
| Former | The patent has been granted Status updated on 03.07.2020 | ||
| Former | Grant of patent is intended Status updated on 02.01.2020 | ||
| Former | Examination is in progress Status updated on 03.04.2019 | ||
| Former | Request for examination was made Status updated on 20.03.2017 | ||
| Former | The international publication has been made Status updated on 09.12.2016 | Most recent event Tooltip | 19.12.2025 | Lapse of the patent in a contracting state New state(s): TR | published on 21.01.2026 [2026/04] | Applicant(s) | For all designated states Massachusetts Institute Of Technology 77 Massachusetts Avenue Cambridge, MA 02139 / US | For all designated states The Brigham and Women's Hospital, Inc. 75 Francis Street Boston, MA 02115 / US | For all designated states Tokitae LLC 11235 SE 6th Street, Suite 200 Bellevue, WA 98004 / US | [2017/16] | Inventor(s) | 01 /
ZHANG, Shiyi 10 Hamlin Street, Floor 2 Cambridge, MA 02141 / US | 02 /
BELLINGER, Andrew 30 Standish Road Wellesley, MA 02181 / US | 03 /
TRAVERSO, Carlo, Giovanni 3938 Bloor Street West Etobicoke, Ontario M9B 1M1 / CA | 04 /
LANGER, Robert, S. 98 Montvale Road Newton, MA 02459 / US | 05 /
GLETTIG, Dean, Liang 24 Antrim Street Apt. 1 Cambridge, MA 02139 / US | 06 /
WOOD, Lowell, L., Jr. 989 112th Avenue N.E. 2310 Bellevue, WA 98004 / US | 07 /
ECKHOFF, Philip, A. 4230 105th Avenue N.E. Kirkland, WA 98033 / US | [2017/16] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2017/16] | Application number, filing date | 15806483.2 | 11.06.2015 | [2017/16] | WO2015US35425 | Priority number, date | US201462010992P | 11.06.2014 Original published format: US 201462010992 P | [2017/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015191922 | Date: | 17.12.2015 | Language: | EN | [2015/50] | Type: | A1 Application with search report | No.: | EP3154553 | Date: | 19.04.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.12.2015 takes the place of the publication of the European patent application. | [2017/16] | Type: | B1 Patent specification | No.: | EP3154553 | Date: | 05.08.2020 | Language: | EN | [2020/32] | Search report(s) | International search report - published on: | US | 17.12.2015 | (Supplementary) European search report - dispatched on: | EP | 23.02.2018 | Classification | IPC: | A61M31/00, A61M29/04, A61K9/00 | [2018/13] | CPC: |
A61K9/0065 (EP,IL,KR,RU,US);
A61M31/002 (IL,US);
A61K31/357 (EP,IL,RU,US);
A61K31/65 (EP,IL,RU,US);
A61K31/7048 (EP,IL,RU,US);
A61K47/10 (IL,US);
A61K47/30 (IL);
A61K47/32 (IL,US);
A61K47/34 (IL,US);
A61K47/38 (IL);
A61K47/40 (IL,US);
A61K47/42 (IL,US);
A61K47/58 (EP,IL,RU,US);
A61K47/6901 (EP,IL,RU,US);
A61K9/0053 (IL,US);
A61K9/48 (IL,US);
C08G18/4277 (EP,IL,RU,US);
C08G18/73 (EP,IL,RU,US);
C08G63/08 (EP,IL,RU,US);
C08G83/006 (IL,US);
C08L33/02 (IL,US);
C08L33/08 (IL,US);
C08L33/14 (IL,US);
C08G2230/00 (IL,US);
|
| Former IPC [2017/16] | A61K31/78, A61K31/197, C07C57/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/16] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | Title | German: | ENTERALE ELASTOMERE | [2017/16] | English: | ENTERIC ELASTOMERS | [2017/16] | French: | ÉLASTOMÈRES ENTÉRIQUES | [2017/16] | Entry into regional phase | 29.12.2016 | National basic fee paid | 29.12.2016 | Search fee paid | 29.12.2016 | Designation fee(s) paid | 29.12.2016 | Examination fee paid | Examination procedure | 29.12.2016 | Examination requested [2017/16] | 29.12.2016 | Date on which the examining division has become responsible | 10.09.2018 | Amendment by applicant (claims and/or description) | 08.04.2019 | Despatch of a communication from the examining division (Time limit: M04) | 14.08.2019 | Reply to a communication from the examining division | 03.01.2020 | Communication of intention to grant the patent | 13.05.2020 | Fee for grant paid | 13.05.2020 | Fee for publishing/printing paid | 13.05.2020 | Receipt of the translation of the claim(s) | Opposition(s) | 07.05.2021 | No opposition filed within time limit [2021/28] | Fees paid | Renewal fee | 27.06.2017 | Renewal fee patent year 03 | 27.06.2018 | Renewal fee patent year 04 | 27.06.2019 | Renewal fee patent year 05 | 29.06.2020 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 11.06.2015 | AL | 05.08.2020 | AT | 05.08.2020 | CY | 05.08.2020 | CZ | 05.08.2020 | DK | 05.08.2020 | EE | 05.08.2020 | ES | 05.08.2020 | FI | 05.08.2020 | HR | 05.08.2020 | IT | 05.08.2020 | LT | 05.08.2020 | LV | 05.08.2020 | MC | 05.08.2020 | MK | 05.08.2020 | MT | 05.08.2020 | NL | 05.08.2020 | PL | 05.08.2020 | RO | 05.08.2020 | RS | 05.08.2020 | SE | 05.08.2020 | SI | 05.08.2020 | SK | 05.08.2020 | SM | 05.08.2020 | TR | 05.08.2020 | BG | 05.11.2020 | NO | 05.11.2020 | GR | 06.11.2020 | IS | 05.12.2020 | PT | 07.12.2020 | [2026/04] |
| Former [2024/41] | HU | 11.06.2015 | |
| AL | 05.08.2020 | ||
| AT | 05.08.2020 | ||
| CY | 05.08.2020 | ||
| CZ | 05.08.2020 | ||
| DK | 05.08.2020 | ||
| EE | 05.08.2020 | ||
| ES | 05.08.2020 | ||
| FI | 05.08.2020 | ||
| HR | 05.08.2020 | ||
| IT | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| LV | 05.08.2020 | ||
| MC | 05.08.2020 | ||
| MK | 05.08.2020 | ||
| MT | 05.08.2020 | ||
| NL | 05.08.2020 | ||
| PL | 05.08.2020 | ||
| RO | 05.08.2020 | ||
| RS | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| SI | 05.08.2020 | ||
| SK | 05.08.2020 | ||
| SM | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| GR | 06.11.2020 | ||
| IS | 05.12.2020 | ||
| PT | 07.12.2020 | ||
| Former [2024/22] | HU | 11.06.2015 | |
| AL | 05.08.2020 | ||
| AT | 05.08.2020 | ||
| CY | 05.08.2020 | ||
| CZ | 05.08.2020 | ||
| DK | 05.08.2020 | ||
| EE | 05.08.2020 | ||
| ES | 05.08.2020 | ||
| FI | 05.08.2020 | ||
| HR | 05.08.2020 | ||
| IT | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| LV | 05.08.2020 | ||
| MC | 05.08.2020 | ||
| MK | 05.08.2020 | ||
| NL | 05.08.2020 | ||
| PL | 05.08.2020 | ||
| RO | 05.08.2020 | ||
| RS | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| SI | 05.08.2020 | ||
| SK | 05.08.2020 | ||
| SM | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| GR | 06.11.2020 | ||
| IS | 05.12.2020 | ||
| PT | 07.12.2020 | ||
| Former [2023/30] | HU | 11.06.2015 | |
| AL | 05.08.2020 | ||
| AT | 05.08.2020 | ||
| CY | 05.08.2020 | ||
| CZ | 05.08.2020 | ||
| DK | 05.08.2020 | ||
| EE | 05.08.2020 | ||
| ES | 05.08.2020 | ||
| FI | 05.08.2020 | ||
| HR | 05.08.2020 | ||
| IT | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| LV | 05.08.2020 | ||
| MC | 05.08.2020 | ||
| NL | 05.08.2020 | ||
| PL | 05.08.2020 | ||
| RO | 05.08.2020 | ||
| RS | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| SI | 05.08.2020 | ||
| SK | 05.08.2020 | ||
| SM | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| GR | 06.11.2020 | ||
| IS | 05.12.2020 | ||
| PT | 07.12.2020 | ||
| Former [2023/29] | HU | 11.06.2015 | |
| AL | 05.08.2020 | ||
| AT | 05.08.2020 | ||
| CZ | 05.08.2020 | ||
| DK | 05.08.2020 | ||
| EE | 05.08.2020 | ||
| ES | 05.08.2020 | ||
| FI | 05.08.2020 | ||
| HR | 05.08.2020 | ||
| IT | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| LV | 05.08.2020 | ||
| MC | 05.08.2020 | ||
| NL | 05.08.2020 | ||
| PL | 05.08.2020 | ||
| RO | 05.08.2020 | ||
| RS | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| SI | 05.08.2020 | ||
| SK | 05.08.2020 | ||
| SM | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| GR | 06.11.2020 | ||
| IS | 05.12.2020 | ||
| PT | 07.12.2020 | ||
| Former [2022/08] | AL | 05.08.2020 | |
| AT | 05.08.2020 | ||
| CZ | 05.08.2020 | ||
| DK | 05.08.2020 | ||
| EE | 05.08.2020 | ||
| ES | 05.08.2020 | ||
| FI | 05.08.2020 | ||
| HR | 05.08.2020 | ||
| IT | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| LV | 05.08.2020 | ||
| MC | 05.08.2020 | ||
| NL | 05.08.2020 | ||
| PL | 05.08.2020 | ||
| RO | 05.08.2020 | ||
| RS | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| SI | 05.08.2020 | ||
| SK | 05.08.2020 | ||
| SM | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| GR | 06.11.2020 | ||
| IS | 05.12.2020 | ||
| PT | 07.12.2020 | ||
| Former [2021/36] | AL | 05.08.2020 | |
| AT | 05.08.2020 | ||
| CZ | 05.08.2020 | ||
| DK | 05.08.2020 | ||
| EE | 05.08.2020 | ||
| ES | 05.08.2020 | ||
| FI | 05.08.2020 | ||
| HR | 05.08.2020 | ||
| IT | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| LV | 05.08.2020 | ||
| NL | 05.08.2020 | ||
| PL | 05.08.2020 | ||
| RO | 05.08.2020 | ||
| RS | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| SI | 05.08.2020 | ||
| SK | 05.08.2020 | ||
| SM | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| GR | 06.11.2020 | ||
| IS | 05.12.2020 | ||
| PT | 07.12.2020 | ||
| Former [2021/34] | AL | 05.08.2020 | |
| AT | 05.08.2020 | ||
| CZ | 05.08.2020 | ||
| DK | 05.08.2020 | ||
| EE | 05.08.2020 | ||
| ES | 05.08.2020 | ||
| FI | 05.08.2020 | ||
| HR | 05.08.2020 | ||
| IT | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| LV | 05.08.2020 | ||
| NL | 05.08.2020 | ||
| PL | 05.08.2020 | ||
| RO | 05.08.2020 | ||
| RS | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| SK | 05.08.2020 | ||
| SM | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| GR | 06.11.2020 | ||
| IS | 05.12.2020 | ||
| PT | 07.12.2020 | ||
| Former [2021/28] | AL | 05.08.2020 | |
| AT | 05.08.2020 | ||
| CZ | 05.08.2020 | ||
| DK | 05.08.2020 | ||
| EE | 05.08.2020 | ||
| ES | 05.08.2020 | ||
| FI | 05.08.2020 | ||
| HR | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| LV | 05.08.2020 | ||
| NL | 05.08.2020 | ||
| PL | 05.08.2020 | ||
| RO | 05.08.2020 | ||
| RS | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| SK | 05.08.2020 | ||
| SM | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| GR | 06.11.2020 | ||
| IS | 05.12.2020 | ||
| PT | 07.12.2020 | ||
| Former [2021/25] | AL | 05.08.2020 | |
| AT | 05.08.2020 | ||
| CZ | 05.08.2020 | ||
| DK | 05.08.2020 | ||
| EE | 05.08.2020 | ||
| ES | 05.08.2020 | ||
| FI | 05.08.2020 | ||
| HR | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| LV | 05.08.2020 | ||
| NL | 05.08.2020 | ||
| PL | 05.08.2020 | ||
| RO | 05.08.2020 | ||
| RS | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| SM | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| GR | 06.11.2020 | ||
| IS | 05.12.2020 | ||
| PT | 07.12.2020 | ||
| Former [2021/22] | AT | 05.08.2020 | |
| CZ | 05.08.2020 | ||
| DK | 05.08.2020 | ||
| EE | 05.08.2020 | ||
| ES | 05.08.2020 | ||
| FI | 05.08.2020 | ||
| HR | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| LV | 05.08.2020 | ||
| NL | 05.08.2020 | ||
| PL | 05.08.2020 | ||
| RO | 05.08.2020 | ||
| RS | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| SM | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| GR | 06.11.2020 | ||
| IS | 05.12.2020 | ||
| PT | 07.12.2020 | ||
| Former [2021/20] | AT | 05.08.2020 | |
| DK | 05.08.2020 | ||
| ES | 05.08.2020 | ||
| FI | 05.08.2020 | ||
| HR | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| LV | 05.08.2020 | ||
| NL | 05.08.2020 | ||
| PL | 05.08.2020 | ||
| RS | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| GR | 06.11.2020 | ||
| IS | 05.12.2020 | ||
| PT | 07.12.2020 | ||
| Former [2021/12] | AT | 05.08.2020 | |
| ES | 05.08.2020 | ||
| FI | 05.08.2020 | ||
| HR | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| LV | 05.08.2020 | ||
| NL | 05.08.2020 | ||
| PL | 05.08.2020 | ||
| RS | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| GR | 06.11.2020 | ||
| IS | 05.12.2020 | ||
| PT | 07.12.2020 | ||
| Former [2021/10] | AT | 05.08.2020 | |
| ES | 05.08.2020 | ||
| FI | 05.08.2020 | ||
| HR | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| LV | 05.08.2020 | ||
| PL | 05.08.2020 | ||
| RS | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| GR | 06.11.2020 | ||
| IS | 05.12.2020 | ||
| PT | 07.12.2020 | ||
| Former [2021/09] | AT | 05.08.2020 | |
| ES | 05.08.2020 | ||
| FI | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| GR | 06.11.2020 | ||
| PT | 07.12.2020 | ||
| Former [2021/08] | ES | 05.08.2020 | |
| FI | 05.08.2020 | ||
| LT | 05.08.2020 | ||
| SE | 05.08.2020 | ||
| BG | 05.11.2020 | ||
| NO | 05.11.2020 | ||
| PT | 07.12.2020 | ||
| Former [2021/07] | FI | 05.08.2020 | |
| LT | 05.08.2020 | ||
| NO | 05.11.2020 | Documents cited: | Search | [XY] US2010316712 (NANGIA AVINASH et al.) [X] 1-7,10-15 * paragraphs [0594] , [0776] , [0999]; example 17 *[Y] 1-15 | [XY] US2005165136 (MAYS JIMMY W et al.) [X] 1-6,13,15 * examples 16,18b *[Y] 1-15 | [A] EP2324822 (TYCO HEALTHCARE et al.) [A] 1-15 * paragraphs [0057] - [0059] * | [Y] EP1911518 (SHIGA PREFECTURE et al.) [Y] 1-15 * examples 1-21 * | International search | [XY] US2005165136 (MAYS JIMMY W et al.) [X] 1, 31 * ; abstract; paragraphs [0007], [0023]-[0024], [0027]-[0028], [0030]-[0031], [0054]-[0055] *[Y] 2-3, 4/1-3, 16 | [X] US3154461 (JOHNSON DOUGLAS L et al.) [X] 29 * ; column 1, lines 25-35; column 3, fines 10-15 column 4, lines 40-45 * | [Y] WO2013049188 (UNIV NORTHEASTERN et al.) [Y] 2-3, 4/1-3, 16 * ; paragraphs [0005], [0085], [0186], [0246]; figure 13B * | [A] US5491586 (PHILLIPS EDWARD D et al.) [A] 29 * ; entire publication * | by applicant | US2010316712 | US2005165136 | EP1911518 | "Goodman and Gilman's The Pharmacological Basis of Therapeutics", 2001, MCGRAW HILL, article "United States Pharmacopeia (USP" | APPLETONLANGE: "Basic and Clinical Pharmacology", 21 September 2000, MCGRAW-HILL | "The Merck Manual of Diagnosis and Therapy", 1999, THOMSON PUBLISHING | "The Merck Veterinary Manual", 2005, MERCK PUBLISHING GROUP | "Orange Book", UNITED STATES FOOD AND DRUG ADMINISTRATION (F.D.A., article "Approved Drug Products with Therapeutic Equivalence and Evaluations" |